Assembly of adiponectin oligomers

Reviews in Endocrine and Metabolic Disorders

Volumn 15, Issue 2, 2014, Pages 125-136

  Tsao, Tsu Shuen ^a  

^a University of Arizona   (United States)

Author keywords

Adipokine; Adiponectin; Collagen; Oligomerization; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; CHAPERONE; DISULFIDE; OLIGOMER; OXIDOREDUCTASE;

AMINO ACID SEQUENCE; BIOCHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); DISULFIDE BOND; HUMAN; IN VITRO STUDY; NONHUMAN; OLIGOMERIZATION; OXIDATION REDUCTION STATE; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SECRETORY PATHWAY; STEADY STATE; ADIPOSE TISSUE; BIOCHEMISTRY; METABOLISM; PHYSIOLOGY;

ADIPONECTIN; ADIPOSE TISSUE; BIOCHEMICAL PROCESSES; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84901431437     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-013-9256-6     Document Type: Review

References (114)

1. Ailhaud G. Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. C R Biol. 2006;329(8):570-7. discussion 653-5.
2. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. Anovel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270(45):26746-9.
3. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996;271(18):10697-703. (Pubitemid 26145805)
4. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996;221(2):286-9. (Pubitemid 26136463)
5. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem. 1996;120(4):803-12. (Pubitemid 26385421)
6. Tsao T-S, Lodish HF, Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Eur J Pharmacol. 2002;440(2-3):213-21. (Pubitemid 34458025)
7. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20(6):1595-9. (Pubitemid 30353893)
8. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86(8):3815-9. (Pubitemid 32755982)
9. Qiang L, Wang H, Farmer SR. Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulumoxidoreductase Ero1-L alpha. Mol Cell Biol. 2007;27(13):4698-707. (Pubitemid 47016124)
10. Seino Y, Hirose H, Saito I, Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanesemen. Metabolism. 2007;56(11):1493-9. (Pubitemid 47562499)
11. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179-88.
12. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24(1):29-33. (Pubitemid 38082408)
13. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006;8(3):264-80.
14. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem. 2003;278(11):9073-85. (Pubitemid 36800387)
15. Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond). 2008;32 Suppl 7:S13-8.
16. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med. 2006;16(5):141-6. (Pubitemid 43867326)
17. Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med. 2009;6(1):27-35.
18. Nanayakkara G, Kariharan T, Wang L, Zhong J, Amin R. The cardio-protective signaling and mechanisms of adiponectin. Am J Cardiovasc Dis. 2012;2(4):253-66.
19. Maddineni S, Metzger S, Ocón O, Hendricks G, Ramachandran R. Adiponectin gene is expressed in multiple tissues in the chicken: food deprivation influences adiponectin messenger ribonucleic acid expression. Endocrinology. 2005;146(10):4250-6. (Pubitemid 41324020)
20. Wang ZV, Scherer PE. Adiponectin, cardiovascular function, and hypertension. Hypertension. 2008;51(1):8-14. (Pubitemid 350307092)
21. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin:more than just another fat cell hormone? Diabetes Care. 2003;26(8):2442.
22. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005;257(2):167-75. (Pubitemid 40193966)
23. Wong GW, Wang J, Hug C, Tsao T-S, Lodish HF. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci U S A. 2004;101(28):10302-7. (Pubitemid 38924920)
24. You M, Rogers CQ. Adiponectin: a key adipokine in alcoholic fatty liver. Exp Biol Med (Maywood). 2009;234(8):850-9.
25. Wang Y, Lam KSL, Yau M-H, Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J. 2008;409(3):623-33. (Pubitemid 351214189)
26. Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol. 1998;8(6):335-8. (Pubitemid 28159119)
27. Min X, Lemon B, Tang J, Liu Q, Zhang R, Walker N, et al. Crystal structure of a single-chain trimer of human adiponectin globular domain. FEBS Lett. 2012;586(6):912-7.
28. Tsao T-S, Murrey HE, Hug C, Lee DH, Lodish HF. Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem. 2002;277(33):29359- 62. (Pubitemid 41079218)
29. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003;278(41):40352-63. (Pubitemid 37248604)
30. Koide T, Nagata K. Collagen. In: Brinckmann J, Notbohm H, Müller PK, editors. Collagen. Springer: Berlin; n.d.
31. Hausrath AC, Goriely A. The Fourier transforms of curves and filaments and their application to low-resolution protein crystallography. J Appl Cryst. 2009;42(2):268-78.
32. Tsao T-S, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem. 2003;278(50):50810-7. (Pubitemid 37548930)
33. Frizzell N, Rajesh M, Jepson MJ, Nagai R, Carson JA, Thorpe SR, et al. Succination of thiol groups in adipose tissue proteins in diabetes: succination inhibits polymerization and secretion of adiponectin. J Biol Chem. 2009;284(38):25772-81.
34. Hada Y, Yamauchi T, Waki H, Tsuchida A, Hara K, Yago H, et al. Selective purification and characterization of adiponectin multimer species from human plasma. Biochem Biophys Res Commun. 2007;356(2):487-93. (Pubitemid 46454397)
35. Mashalidis EH, Briggs DB, Zhou M, Vergara AM, Chhun JJ, Ellsworth RK, et al. High-resolution identification of human adiponectin oligomers and regulation by pioglitazone in type 2 diabetic patients. Anal Biochem. 2013;437(2):150-60.
36. Schraw T, Wang ZV, Halberg N, Hawkins M, Scherer PE. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology. 2008;149(5):2270-82. (Pubitemid 351574488)
37. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes. 2006;55(1):249-59. (Pubitemid 43343322)
38. Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert MO, et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes. 2005;54(9):2712-9. (Pubitemid 41233594)
39. Xu A, Chan KW, Hoo RLC, Wang Y, Tan KCB, Zhang J, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005;280(18):18073-80. (Pubitemid 41389052)
40. Briggs DB, Jones CM, Mashalidis EH, Nuñez M, Hausrath AC, Wysocki VH, et al. Disulfide-dependent self-assembly of adiponectin octadecamers from trimers and presence of stable octadecameric adiponectin lacking disulfide bonds in vitro. Biochemistry. 2009;48(51):12345-57.
41. Suzuki S, Wilson-Kubalek EM, Wert D, Tsao T-S, Lee DH. The oligomeric structure of high molecular weight adiponectin. FEBS Lett. 2007;581(5):809-14. (Pubitemid 46282708)
42. Niemann B, Pan R, Teschner M, Boening A, Silber R-E, Rohrbach S. Age and obesity-associated changes in the expression and activation of components of the AMPK signaling pathway in human right atrial tissue. Exp Gerontol. 2012.
43. Fisher FFM, Trujillo ME, Hanif W, Barnett AH, McTernan PG, Scherer PE, et al. Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia. 2005;48(6):1084-7. (Pubitemid 40909642)
44. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004;279(13):12152-62. (Pubitemid 38445780)
45. Abbasi F, Chang S-A, Chu JW, Ciaraldi TP, Lamendola C, McLaughlin T, et al. Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol. 2006;290(1):R139-44.
46. Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, et al. Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans. Am J Physiol Endocrinol Metab. 2009;297(3):E767-73.
47. Peake PW, Kriketos AD, Campbell LV, Shen Y, Charlesworth JA. The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol. 2005;153(3):409-17. (Pubitemid 41410498)
48. Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, Goldstein BJ. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res. 2008;78(2):376-84. (Pubitemid 351556105)
49. Amin RH, Mathews ST, Camp HS, Ding L, Leff T. Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from dietinduced insulin resistance. Am J Physiol Endocrinol Metab. 2010;298(1):E28-37.
50. Ebinuma H, Miida T, Yamauchi T, Hada Y, Hara K, Kubota N, et al. Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid. Clin Chem. 2007;53(8):1541-4. (Pubitemid 47206353)
51. Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMWadiponectin. Diabetes. 2006;55(7):1954-60. (Pubitemid 44509967)
52. Sinha MK, Songer T, Xiao Q, Sloan JH, Wang J, Ji S, et al. Analytical validation and biological evaluation of a high molecular-weight adiponectin ELISA. Clin Chem. 2007;53(12):2144-51. (Pubitemid 350197298)
53. Wang Y, Lam KSL, Chan L, Chan KW, Lam JBB, Lam MC, et al. Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J Biol Chem. 2006;281(24):16391-400.
54. Peake PW, Hughes JT, Shen Y, Charlesworth JA. Glycosylation of human adiponectin affects its conformation and stability. J Mol Endocrinol. 2007;39(1):45-52. (Pubitemid 47337865)
55. Pajvani UB, Scherer PE. Adiponectin: systemic contributor to insulin sensitivity. Curr Diab Rep. 2003;3(3):207-13. (Pubitemid 38906774)
56. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004;10(12):1384-9. (Pubitemid 40022722)
57. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology. 2004;145(1):367-83. (Pubitemid 38094532)
58. Halberg N, Schraw TD, Wang ZV, Kim J-Y, Yi J, Hamilton MP, et al. Systemic fate of the adipocyte-derived factor adiponectin. Diabetes. 2009;58(9):1961-70.
59. Kim J-A, Nuñez M, Briggs DB, Laskowski BL, Chhun JJ, Eleid JK, et al. Extracellular conversion of adiponectin hexamers into trimers. Biosci Rep. 2012;32(6):641-52.
60. Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes. 2007;56(8):2174-7. (Pubitemid 47195840)
61. O'Leary VB, Jorett AE, Marchetti CM, Gonzalez F, Phillips SA, Ciaraldi TP, et al. Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults. Am J Physiol Endocrinol Metab. 2007;293(1):E421-7. (Pubitemid 47105958)
62. Aso Y, Yamamoto R, Suetsugu M, Matsumoto S, Wakabayashi S, Matsutomo R, et al. Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with type 2 diabetes. Diabet Med. 2007;24(9):962-8. (Pubitemid 47301641)
63. Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med. 2008;149(5):307-16.
64. Blüher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, et al. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care. 2007;30(2):280-5. (Pubitemid 46198331)
65. Komura N, Kihara S, Sonoda M, Kumada M, Fujita K, Hiuge A, et al. Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J. 2008;72(1):23-8. (Pubitemid 351413321)
66. Almeda-Valdes P, Cuevas-Ramos D, Mehta R, Gomez-Perez FJ, Cruz-Bautista I, Arellano-Campos O, et al. Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc Diabetol. 2010;9:26.
67. Liu Y, Retnakaran R, Hanley A, Tungtrongchitr R, Shaw C, Sweeney G. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. J Clin Endocrinol Metab. 2007;92(11):4313-8. (Pubitemid 350074750)
68. Wang AY-H, Hickman IJ, Richards AA, Whitehead JP, Prins JB, Macdonald GA. High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection. Am J Gastroenterol. 2005;100(12):2717-23.
69. Richards AA, Colgrave ML, Zhang J, Webster J, Simpson F, Preston E, et al. Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulation. Mol Endocrinol. 2010;24(1):229-39.
70. Inoue T, Takemori K, Yamamoto K, Ito H. Characterization of Wistar-Kyoto rats showing hyperadiponectinemia. Life Sci. 2010;86(9-10):344-50.
71. Morisaki H, Yamanaka I, Iwai N, Miyamoto Y, Kokubo Y, Okamura T, et al. CDH13 gene coding t-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat. 2012;33(2):402-10.
72. Williams AS, Kasahara DI, Verbout NG, Fedulov AV, Zhu M, Si H, et al. Role of the adiponectin binding protein, T-cadherin (Cdh13), in allergic airways responses inmice. PLoS One. 2012;7(7):e41088.
73. Phillips SA, Ciaraldi TP, Oh DK, Savu MK, Henry RR. Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue. Am J Physiol Endocrinol Metab. 2008;295(4):E842-50.
74. Rasouli N, Yao-Borengasser A, Miles LM, Elbein SC, Kern PA. Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am J Physiol Endocrinol Metab. 2006;290(1):E42-6.
75. Savu MK, Phillips SA, Oh DK, Park K, Gerlan C, Ciaraldi TP, et al. Response of adiponectin and its receptors to changes in metabolic state after gastric bypass surgery: dissociation between adipose tissue expression and circulating levels. Surg Obes Relat Dis. 2009;5(2):172-80.
76. Wang ZV, Schraw TD, Kim J-Y, Khan T, Rajala MW, Follenzi A, et al. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol Cell Biol. 2007;27(10):3716-31. (Pubitemid 46726179)
77. Liu M, Zhou L, Xu A, Lam KSL, Wetzel MD, Xiang R, et al. A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci U S A. 2008;105(47):18302-7.
78. Liu M, Xiang R, Wilk SA, Zhang N, Sloane LB, Azarnoush K, et al. Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance. Diabetes. 2012;61(11):2776-86.
79. Zhou L, Liu M, Zhang J, Chen H, Dong LQ, Liu F. DsbA-L alleviates endoplasmic reticulum stress-induced adiponectin downregulation. Diabetes. 2010;59(11):2809-16.
80. Radjainia M, Wang Y, Mitra AK. Structural polymorphism of oligomeric adiponectin visualized by electron microscopy. J Mol Biol. 2008;381(2):419-30.
81. Briggs DB, Giron RM, Malinowski PR, Nunez M, Tsao T-S. Role of redox environment on the oligomerization of higher molecular weight adiponectin. BMC Biochem. 2011;12(1):24.
82. Briggs DB, Giron RM, Schnittker K, Hart MV, Park CK, Hausrath AC, et al. Zinc enhances adiponectin oligomerization to octadecamers but decreases the rate of disulfide bond formation. Biometals. 2012;25(2):469-86.
83. Banga A, Bodles AM, Rasouli N, Ranganathan G, Kern PA, Owens RJ. Calcium is involved in formation of high molecular weight adiponectin. Metab Syndr Relat Disord. 2008;6(2):103-11. (Pubitemid 351769258)
84. Richards AA, Stephens T, Charlton HK, Jones A, Macdonald GA, Prins JB, et al. Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications. Mol Endocrinol. 2006;20(7):1673-87. (Pubitemid 43967574)
85. Wang Y, Xu A, Knight C, Xu LY, Cooper GJS. Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity. J Biol Chem. 2002;277(22):19521-9. (Pubitemid 34967464)
86. Wang Y, Lu G, Wong WPS, Vliegenthart JFG, Gerwig GJ, Lam KSL, et al. Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics. 2004;4(12):3933-42. (Pubitemid 39657468)
87. Sato C, Yasukawa Z, Honda N, Matsuda T, Kitajima K. Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue specific glycoprotein, adipo Q. J Biol Chem. 2001;29:29.
88. Butler WT, Cunningham LW. Evidence for the linkage of a disaccharide to hydroxylysine in tropocollagen. J Biol Chem. 1966;241(17):3882-8.
89. Yonemasu K, Shinkai H, Sasaki T. Comparable content of hydroxylysine-linked glycosides in subcomponents C1q of the first component of human, bovine and mouse complement. Coll Relat Res. 1981;1(4):385-90. (Pubitemid 12251601)
90. Bann JG, Peyton DH, Bächinger HP. Sweet is stable: glycosylation stabilizes collagen. FEBS Lett. 2000;473(2):237-40. (Pubitemid 30254298)
91. Bann JG, Bächinger HP. Glycosylation/hydroxylation-induced stabilization of the collagen triple helix. 4-trans-hydroxyproline in the Xaa position can stabilize the triple helix. J Biol Chem. 2000;275(32):24466-9. (Pubitemid 30626538)
92. Brodsky B, Shah NK. Protein motifs. 8. The triple-helix motif in proteins. FASEB J. 1995;9(15):1537-46.
93. Brodsky-Doyle B, Leonard KR, Reid KB. Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. Biochem J. 1976;159(2):279-86.
94. Cortini M, Sitia R. Fromantibodies to adiponectin: role of ERp44 in sizing and timing protein secretion. Diabetes Obes Metab. 2010;12 Suppl 2:39-47.
95. Ladner JE, Parsons JF, Rife CL, Gilliland GL, Armstrong RN. Parallel evolutionary pathways for glutathione transferases: structure and mechanism of the mitochondrial class kappa enzyme rGSTK1-1. Biochemistry. 2004;43(2):352-61. (Pubitemid 38082557)
96. Pemble SE, Wardle AF, Taylor JB. Glutathione S-transferase class Kappa: characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem J. 1996;319(Pt 3):749-54. (Pubitemid 26386186)
97. Morel F, Aninat C. The glutathione transferase kappa family. Drug Metab Rev. 2011;43(2):281-91.
98. Theodoratos A, Blackburn AC, Coggan M, Cappello J, Larter CZ, Matthaei KI, et al. The impact of glutathione transferase kappa deficiency on adiponectin multimerisation in vivo . Int J Obes (Lond). 2012;36(10):1366-9.
99. Sevier CS, Kaiser CA. Ero1 and redox homeostasis in the endoplasmic reticulum. Biochim Biophys Acta. 2008;1783(4):549-56.
100. Freedman RB. A non-catalytic disulphide bond regulating redox flux in the ER oxidative folding pathway. EMBO J. 2009;28(3):169-70.
101. Tsao TS, Hug C, Lodish HF. Adipokines: regulators of metabolic integration and energy metabolism. In: LeRoith D, Taylor SI, Olefsky JM, editors. Diabetes mellitus: a fundamental and clinical text (3rd ed, Chapter 65, p xviii, 1540 p.). Philadelphia: Lippincott Williams & Wilkins.
102. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111-9. (Pubitemid 40629025)
103. Merksamer PI, Trusina A, Papa FR. Real-time redox measurements during endoplasmic reticulum stress reveal interlinked protein folding functions. Cell. 2008;135(5):933-47.
104. Avezov E, Cross BCS, Kaminski Schierle GS, Winters M, Harding HP, Melo EP, et al. Lifetime imaging of a fluorescent protein sensor reveals surprising stability of ER thiol redox. J Cell Biol. 2013;201(2):337-49.
105. Margittai E, Sitia R. Oxidative protein folding in the secretory pathway and redox signaling across compartments and cells. Traffic. 2011;12(1):1-8.
106. Appenzeller-Herzog C. Glutathione- and non-glutathione-based oxidant control in the endoplasmic reticulum. J Cell Sci. 2011;124(6):847-55.
107. Radjainia M, Huang B, Bai B, Schmitz M, Yang SH, Harris PWR, et al. A highly conserved tryptophan in the N-terminal variable domain regulates disulfide bond formation and oligomeric assembly of adiponectin. FEBS J. 2012.
108. Riera-Guardia N, Rothenbacher D. The effect of thiazolidinediones on adiponectin serum level: a meta-analysis. Diabetes Obes Metab. 2008;10(5):367-75. (Pubitemid 351524284)
109. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001;50(9):2094-9. (Pubitemid 33643677)
110. Zeng Q, Fu L, Takekoshi K, Kawakami Y, Isobe K. Effects of short-term exercise on adiponectin and adiponectin receptor levels in rats. J Atheroscler Thromb. 2007;14(5):261-5.
111. Wang B, Wood IS, Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch. 2007;455(3):479-92. (Pubitemid 47624196)
112. Coughlin CC, Finck BN, Eagon JC, Halpin VJ, Magkos F, Mohammed BS, et al. Effect of marked weight loss on adiponectin gene expression and plasma concentrations. Obesity (Silver Spring). 2007;15(3):640-5. (Pubitemid 46643317)
113. Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, et al. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes. 2004;53(6):1621-9. (Pubitemid 38697679)
114. Bodles AM, Banga A, Rasouli N, Ono F, Kern PA, Owens RJ. Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes. Am J Physiol Endocrinol Metab. 2006;291(5):E1100-5.